Argatroban and Alfentanil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Argatroban (argatroban) and Alfentanil (alfentanil hydrochloride). Common drug interactions include colitis among females and colitis among males.

The phase IV clinical study analyzes what interactions people have when they take Argatroban and Alfentanil. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Argatroban?

Argatroban has active ingredients of argatroban. eHealthMe is studying from 1,847 Argatroban users. Check the latest studies of Argatroban.

What is Alfentanil?

Alfentanil has active ingredients of alfentanil hydrochloride. eHealthMe is studying from 1,482 Alfentanil users. Check the latest studies of Alfentanil.



On Jul, 07, 2026

28 people who take Argatroban and Alfentanil together, and have interactions are studied.

Argatroban and Alfentanil drug interactions.

What are the common drug interactions of Argatroban and Alfentanil, by gender? *:

female:

  1. Colitis (inflammation of colon)
  2. Abdominal pain
  3. Vomiting
  4. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
  5. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  6. Diarrhoea
  7. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  8. Pneumonia
  9. Rash
  10. Overdose

male:

  1. Colitis (inflammation of colon)
  2. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  3. Overdose
  4. Prostatic specific antigen increased
  5. Pneumatosis intestinalis (air or gas in an intestine)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Acute respiratory distress syndrome
  8. Epistaxis (bleed from the nose)
  9. Mouth haemorrhage (bleeding from mouth)
  10. Multi-organ failure (multisystem organ failure)

What are the common drug interactions of Argatroban and Alfentanil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Vomiting
  2. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
  3. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  4. Diarrhoea
  5. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  6. Pneumonia
  7. Rash
  8. Overdose
  9. Colitis (inflammation of colon)
  10. Abdominal pain

50-59:

n/a

60+:

  1. Colitis (inflammation of colon)
  2. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  3. Pneumatosis intestinalis (air or gas in an intestine)
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Acute respiratory distress syndrome
  6. Epistaxis (bleed from the nose)
  7. Mouth haemorrhage (bleeding from mouth)
  8. Multi-organ failure (multisystem organ failure)

What are the existing conditions these people have? *

  1. Depression: 28 people, 100.00%
  2. Pain: 23 people, 82.14%
  3. Nausea (feeling of having an urge to vomit): 23 people, 82.14%
  4. Breast Cancer Metastatic: 20 people, 71.43%
  5. Blood Magnesium Decreased: 20 people, 71.43%
  6. Neutropenic Sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection): 19 people, 67.86%
  7. Pneumonia: 19 people, 67.86%
  8. Diarrhea: 19 people, 67.86%
  9. Nausea And Vomiting: 15 people, 53.57%
  10. Colitis Ischaemic (due to infection of intestine impaired blood supply to colon): 15 people, 53.57%

* Approximation only. Some reports may have incomplete information.

Do you take Argatroban and Alfentanil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Argatroban and Alfentanil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Argatroban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Alfentanil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Argatroban and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alfentanil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on argatroban and alfentanil hydrochloride (the active ingredients of Argatroban and Alfentanil, respectively), and Argatroban and Alfentanil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: